Search filters

List of works by Bruce R Schackman

'Ending the Epidemic' will not happen without addressing racial/ethnic disparities in the US HIV epidemic

scientific article published on 19 May 2020

2216. Hepatitis C Treatment Wanted Yet Not Received: Barriers to Receiving HCV Treatment Among People Who Inject Drugs

862. Spatial Distribution of HIV Transmission in Ethiopia and Characteristics of HIV Clusters

article

A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination

scientific article published on 01 May 2019

A call for evidence-based medical treatment of opioid dependence in the United States and Canada

scientific article

A cost-benefit analysis of external hip protectors in the nursing home setting

scientific article published in February 2005

A synthesis of cost-utility analysis literature in infectious disease

scientific article

AIDS Drug Assistance Programs: managers confront uncertainty and need to adapt as the Affordable Care Act kicks in.

scientific article published in June 2013

Achieving effective antidepressant pharmacotherapy in primary care: the role of depression care management in treating late-life depression

scientific article published in May 2009

Addressing Barriers to On-site HIV and HCV Testing Services in Methadone Maintenance Treatment Programs in the United States: Findings From a National Multisite Qualitative Study

scientific article published on 16 December 2020

An In-Depth Survey of the Screening and Assessment Practices of Highly Regarded Adolescent Substance Abuse Treatment Programs

scientific article

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential

scientific article

Appropriateness criteria and elective procedures--total joint arthroplasty

scientific article published on 01 December 2012

Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions

scientific article published on 01 October 2018

Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States

scientific article published on 01 October 2018

Budget impact of Medicaid Section 1115 demonstrations for early HIV treatment.

scientific article

Building the Case for Localized Approaches to HIV: Structural Conditions and Health System Capacity to Address the HIV/AIDS Epidemic in Six US Cities

article

Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial

scientific article published on 07 February 2020

COVID-19 Could Change the Way We Respond to the Opioid Crisis-for the Better

scientific article published on 12 August 2020

Can hip protector use cost-effectively prevent fractures in community-dwelling geriatric populations?

scientific article published in November 2006

Can the 'Ending the HIV Epidemic' initiative transition the US towards HIV/AIDS epidemic control?

scientific article published on 10 August 2020

Can urban methadone patients complete health utility assessments?

scientific article published on 7 March 2008

Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patients

scientific article

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing

scientific article

Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting

scientific article

Closing the gaps in opioid use disorder research, policy and practice: conference proceedings

scientific article published on 13 November 2018

Collaborative depression care management and disparities in depression treatment and outcomes

scientific article

Commentary on Barbosa et al. (2019): The value of using community simulation modeling to achieve HCV elimination targets in people who inject drugs

scientific article published on 23 October 2019

Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation

scientific article published on 27 January 2020

Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS

article

Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting

scientific article published on 01 December 2020

Comparison of health state utilities using community and patient preference weights derived from a survey of patients with HIV/AIDS.

scientific article published in January 2002

Controlling the HIV epidemic with antiretrovirals: IAPAC consensus statement on treatment as prevention and preexposure prophylaxis

scientific article published on May 2013

Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1

scientific article

Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer.

scientific article

Cost of an HIV Medical Care Coordination Program in Los Angeles County

scientific article published on 01 May 2019

Cost of pharmacotherapy for opioid use disorders following inpatient detoxification

scientific article published on 01 November 2018

Cost-Effectiveness Analysis of Ugt1A1 Genetic Testing to Inform Antiretroviral Prescribing in HIV Disease ⬇️

scientific article published on December 21, 2012

Cost-Effectiveness of Buprenorphine-Naloxone Versus Extended-Release Naltrexone to Prevent Opioid Relapse

scientific article published on 18 December 2018

Cost-Effectiveness of Earlier Initiation of Antiretroviral Therapy for Uninsured HIV-Infected Adults

article

Cost-Effectiveness of Early Versus Standard Antiretroviral Therapy in HIV-Infected Adults in Haiti ⬇️

scientific article published on September 20, 2011

Cost-Effectiveness of Meningococcal Vaccination Among Men Who Have Sex With Men in New York City

scientific article published on 27 August 2015

Cost-effective Screening for Acute Hepatitis C Virus Infection in HIV-Infected Men Who Have Sex With Men ⬇️

scientific article published on April 4, 2012

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults

scientific article published in November 2002

Cost-effectiveness of Adding an Agent That Improves Immune Responses to Initial Antiretroviral Therapy (ART) in HIV-Infected Patients: Guidance for Drug Development ⬇️

scientific article published on January 1, 2012

Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice

scientific article published on 26 November 2015

Cost-effectiveness of Hepatitis C Virus Treatment Models for People Who Inject Drugs in Opioid Agonist Treatment Programs

scientific article published on 01 March 2020

Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles County

scientific article published on 16 December 2019

Cost-effectiveness of an intervention to improve adherence to antiretroviral therapy in HIV-infected patients

scientific article published in December 2006

Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States.

scientific article

Cost-effectiveness of generic antiretroviral therapy--in response

scientific article published in May 2013

Cost-effectiveness of hepatitis C screening and treatment linkage intervention in US methadone maintenance treatment programs

scientific article published on 13 February 2018

Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids

scientific article published on 10 May 2019

Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care

scientific article

Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs

scientific article

Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti

scientific article

Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India

scientific article published on February 2010

Costs of Expanded Rapid HIV Testing in Four Emergency Departments

scientific article

Cost–effectiveness of pre-exposure prophylaxis for HIV ⬇️

scientific article published on November 1, 2012

Criminal justice measures for economic data harmonization in substance use disorder research

scientific article published on 21 September 2018

Design issues in initial HIV-treatment trials: focus on ACTG A5095.

scientific article published in January 2006

Developing a dynamic HIV transmission model for 6 U.S. cities: An evidence synthesis

scientific article published on 30 May 2019

Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities

scientific article published on 22 December 2019

Dissemination Science to Advance the Use of Simulation Modeling: Our Obligation Moving Forward

scientific article published on 05 August 2020

Does higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs

scientific article

Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164

scientific article

Economic evaluation in the National Drug Abuse Treatment Clinical Trials Network: Past, present, and future

scientific article published on 01 March 2020

Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States

scientific article published on January 2013

Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts

scientific article published in April 2008

Effect of risk-reduction counseling with rapid HIV testing on risk of acquiring sexually transmitted infections: the AWARE randomized clinical trial

scientific article

Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities

scientific article published on 01 November 2019

Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities

scientific article published on 01 September 2020

Ending the HIV epidemic in the USA: an economic modelling study in six cities

scientific article published on 05 March 2020

Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City

scientific article published on 14 August 2019

Evaluation of Alcohol Taxes as a Public Health Opportunity to Reduce Liver Transplant Listings for Alcohol-Related Liver Disease

scientific article published on 17 September 2020

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs

scientific article published in December 2006

Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis.

scientific article

Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique

scientific article published on 10 June 2013

Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care

scientific article published in August 2009

First Opioid Prescription and Subsequent High-Risk Opioid Use: a National Study of Privately Insured and Medicare Advantage Adults

scientific article published on 11 September 2018

HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness

scientific article

HIV rapid testing in substance abuse treatment: Implementation following a clinical trial ⬇️

scientific article published on March 1, 2011

Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study

scientific article published on 03 October 2020

Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure

scientific article published on 08 October 2013

Health-related quality of life and opioid use disorder pharmacotherapy: A secondary analysis of a clinical trial

scientific article published on 05 August 2020

Hepatitis C Treatment Uptake by New Prescribers After the Introduction of Direct Acting Antivirals

scientific article published on 01 March 2020

Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program

scientific article published on 01 September 2020

Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City

scientific article published on 01 September 2020

How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?

scientific article published on 01 January 2004

Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.

scientific article

Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City

scientific article published on 03 February 2020

Implementation of a nationwide health economic consultation service to assist substance use researchers: Lessons learned

scientific article published on 20 March 2018

Implementation science for the prevention and treatment of HIV/AIDS ⬇️

scientific article published on December 1, 2010

Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial.

scientific article published on 19 April 2012

Improving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial

scientific article published on 14 June 2019

Inappropriate Medication in Home Health Care ⬇️

scientific article published on February 3, 2012

Inappropriate Medication in a National Sample of US Elderly Patients Receiving Home Health Care ⬇️

scientific article published on March 1, 2012

Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

scientific article

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression

scientific article published on April 2007

Joint Utility Estimators in Substance Use Disorders.

scientific article published on 17 November 2016

Lives saved by expanding HIV treatment availability in resource-limited settings: the example of Haiti

scientific article published on June 2013

Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population

scientific article published on 24 October 2015

Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up Stroke

scientific article published on 3 February 2016

Monetary conversion factors for economic evaluations of substance use disorders

scientific article published on 18 July 2017

NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs

scientific article

Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults

scientific article published on January 2012

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305

scientific article published in PLoS ONE

Offers of hepatitis C care do not lead to treatment

scientific article

On-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial

scientific article published on 3 March 2016

Overcoming policy and financing barriers to integrated buprenorphine and HIV primary care

scientific article published on December 2006

Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort

scientific article published on 03 May 2019

Performance of a mathematical model to forecast lives saved from HIV treatment expansion in resource-limited settings

scientific article

Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial

scientific article published on 4 September 2007

Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

scientific article

Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects

scientific article published in March 2008

Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?

scientific article published on 24 July 2019

Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians.

scientific article published on June 2016

Preventing vertical hepatitis C virus transmission

scientific article

Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US

scientific article

Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US

article

Proceedings from the 9th annual conference on the science of dissemination and implementation: Washington, DC, USA. 14-15 December 2016.

scientific article

Quality of life as an outcome of opioid use disorder treatment: A systematic review.

scientific article

Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?

scientific article

Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.

scientific article

Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis

scientific article published on 17 September 2013

Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095.

scientific article

Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

scientific article published on 9 February 2018

Response to commentary by Dr. Oliver and colleagues on hip protectors

scientific article published in July 2006

Results from a New York City emergency department rapid HIV testing program

scientific article

Sexually active HIV-positive patients frequently report never using condoms in audio computer-assisted self-interviews conducted at routine clinical visits

scientific article published in February 2008

Short term health-related quality of life improvement during opioid agonist treatment

scientific article published on 25 October 2015

Spatial distribution and characteristics of HIV clusters in Ethiopia

scientific article published on 12 January 2020

State Medicaid hepatitis C treatment eligibility criteria and use of direct acting antivirals.

scientific article published in December 2017

State Policies for Prescription Drug Monitoring Programs and Adverse Opioid-related Hospital Events

scientific article published on 19 March 2020

States With Prescription Drug Monitoring Mandates Saw A Reduction In Opioids Prescribed To Medicaid Enrollees

scientific article published on April 2017

Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity

scientific article published on 01 May 2019

Strengthening partnerships between substance use researchers and policy makers to take advantage of a window of opportunity

scientific article published on 04 March 2019

Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review

scientific article published on 01 October 2019

Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment

scientific article published on 19 February 2019

Substance use and STI acquisition: Secondary analysis from the AWARE study.

scientific article published on 27 October 2016

Telementoring of primary care providers delivering hepatitis C treatment in New York City: Results from Project INSPIRE

scientific article published on 10 May 2018

The FANMI ("my FAMILY" in Creole) study to evaluate community-based cohort care for adolescent and young women living with HIV in Haiti: protocol for a randomized controlled trial

scientific article published on 30 December 2019

The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients

scientific article published on 01 August 2018

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

scientific article

The Value and Challenge of Frequent HIV Testing Among Young Men Who Have Sex With Men in the United States

scientific article published on 30 July 2020

The Value of HIV Screening in the United States in the Era of Effective Treatment ⬇️

scientific article published on May 1, 2013

The clinical role and cost-effectiveness of long-acting antiretroviral therapy

scientific article

The cost of HIV medication adherence support interventions: Results of a cross-site evaluation

article

The cost of antiretroviral therapy in Haiti

scientific article published on 14 February 2008

The cost of implementing rapid HIV testing in sexually transmitted disease clinics in the United States

scientific article

The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.

scientific article published on March 2011

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

scientific article published on October 2008

The cost-effectiveness of elective Cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women

scientific article published in September 2004

The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients

scientific article

The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings

scientific article published on 9 September 2017

The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trial

scientific article published on 9 September 2012

The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection

scientific article published on May 2015

The hepatitis C cascade of care: identifying priorities to improve clinical outcomes

scientific article

The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort

scientific article

The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities

scientific article published on 01 March 2020

The lifetime medical cost savings from preventing HIV in the United States.

scientific article

The potential epidemiological impact of COVID-19 on the HIV/AIDS epidemic and the cost-effectiveness of linked, opt-out HIV testing: A modeling study in six US cities

scientific article published on 12 October 2020

The projected costs and benefits of a supervised injection facility in Seattle, WA, USA

scientific article published on 23 February 2019

The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey

scientific article published in September 2004

The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico

scientific article

The survival benefits of AIDS treatment in the United States

scientific article

The use of an educational video during informed consent in an HIV clinical trial in Haiti

scientific article published in August 2006

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial

scientific article published on August 2006

Treating and Preventing HIV with Generic Drugs - Barriers in the United States.

scientific article published in January 2018

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

scientific article published on April 2004

Updating the HIV-testing guidelines--a modest change with major consequences

scientific article published on 20 February 2013

Variation in orthopaedic surgeons' perceptions about the indications for rotator cuff surgery

scientific article published on 01 September 2005

Variations in self-rated health among patients with HIV infection

scientific article

What does U.S. health reform mean for HIV clinical care?

scientific article published in May 2012

When "the Cure" Is the Risk: Understanding How Substance Use Affects HIV and HCV in a Layered Risk Environment in San Juan, Puerto Rico

scientific article published on September 2017

Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic

article

Will converting naloxone to over-the-counter status increase pharmacy sales?

scientific article published on 20 February 2019

Paulina is supported by:

About Paulina

Help